August 7th, 2025
New Alzheimer’s Breakthrough Targets Disease at the Cellular Level, Shows Promise
A Boston biotech firm has unveiled a first-of-its-kind treatment targeting the root causes of Alzheimer’s using brain organoids, Tau biomarkers, and AI-designed peptides, offering hope beyond symptom relief.